| 标题 |
Fianlimab (anti-LAG-3) + cemiplimab (anti-PD-1) in patients (pts) with advanced melanoma (Mel): Subgroup analyses by blinded independent central review (BICR) |
| 网址 | |
| DOI |
10.1158/1538-7445.AM2025-LB366
doi
|
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)